Literature DB >> 21077815

Cancer incidence and mortality in Indigenous Australians in Queensland, 1997-2006.

Suzanne P Moore1, Peter K O'Rourke, Kylie-Ann Mallitt, Gail Garvey, Adèle C Green, Michael D Coory, Patricia C Valery.   

Abstract

OBJECTIVE: To examine cancer incidence and mortality in Indigenous Queenslanders. DESIGN, SETTING AND PATIENTS: Assessment of indirectly standardised incidence and mortality ratios for Indigenous Australians in Queensland diagnosed with cancer from 1997 to 2006, compared with the total Queensland population. MAIN OUTCOME MEASURES: Standardised incidence and mortality ratios.
RESULTS: Compared with the total Queensland population, Indigenous Queenslanders had a lower overall incidence of cancer (standardised incidence ratio, 0.79; 95% CI, 0.75-0.82), but a higher incidence of some of the more fatal cancer types. Overall cancer mortality was higher (standardised mortality ratio, 1.36; 95% CI, 1.28-1.45) and similar to rates for Indigenous people in other Australian states.
CONCLUSION: Cancer rates for Indigenous Queenslanders, a mostly urbanised population, are similar to rates for Indigenous Australians mostly living in remote areas.

Entities:  

Mesh:

Year:  2010        PMID: 21077815

Source DB:  PubMed          Journal:  Med J Aust        ISSN: 0025-729X            Impact factor:   7.738


  9 in total

1.  Breast cancer diagnosis, patterns of care and burden of disease in Queensland, Australia (1998-2004): does being Indigenous make a difference?

Authors:  Suzanne P Moore; Isabelle Soerjomataram; Adèle C Green; Gail Garvey; Jennifer Martin; Patricia C Valery
Journal:  Int J Public Health       Date:  2015-10-01       Impact factor: 3.380

2.  Young-Onset Gastrointestinal Adenocarcinoma Incidence and Survival Trends in the Northern Territory, Australia, with Emphasis on Indigenous Peoples.

Authors:  Mia Shepherdson; Shalem Leemaqz; Gurmeet Singh; Courtney Ryder; Shahid Ullah; Karla Canuto; Joanne P Young; Timothy J Price; Ross A McKinnon; Stephen J Pandol; Claire T Roberts; Savio George Barreto
Journal:  Cancers (Basel)       Date:  2022-06-10       Impact factor: 6.575

3.  Health service utilization by indigenous cancer patients in Queensland: a descriptive study.

Authors:  Christina M Bernardes; Lisa J Whop; Gail Garvey; Patricia C Valery
Journal:  Int J Equity Health       Date:  2012-10-10

4.  Estimates of cancer incidence, mortality and survival in aboriginal people from NSW, Australia.

Authors:  Stephen Morrell; Hui You; Deborah Baker
Journal:  BMC Cancer       Date:  2012-05-06       Impact factor: 4.430

5.  A study of head and neck cancer treatment and survival among indigenous and non-indigenous people in Queensland, Australia, 1998 to 2004.

Authors:  Suzanne P Moore; Adèle C Green; Gail Garvey; Michael D Coory; Patricia C Valery
Journal:  BMC Cancer       Date:  2011-10-25       Impact factor: 4.430

6.  Prostate cancer mortality outcomes and patterns of primary treatment for Aboriginal men in New South Wales, Australia.

Authors:  Jennifer C Rodger; Rajah Supramaniam; Alison J Gibberd; David P Smith; Bruce K Armstrong; Anthony Dillon; Dianne L O'Connell
Journal:  BJU Int       Date:  2015-04       Impact factor: 5.588

7.  Trends of lip, oral cavity and oropharyngeal cancers in Australia 1982-2008: overall good news but with rising rates in the oropharynx.

Authors:  Anura Ariyawardana; Newell W Johnson
Journal:  BMC Cancer       Date:  2013-07-06       Impact factor: 4.430

8.  Increasing rates of surgical treatment and preventing comorbidities may increase breast cancer survival for Aboriginal women.

Authors:  Rajah Supramaniam; Alison Gibberd; Anthony Dillon; David Eamon Goldsbury; Dianne L O'Connell
Journal:  BMC Cancer       Date:  2014-03-07       Impact factor: 4.430

9.  Characteristics, survival, and related factors of newly diagnosed colorectal cancer patients refusing cancer treatments under a universal health insurance program.

Authors:  Chun-Yi Liu; William Tzu-Liang Chen; Pei-Tseng Kung; Chang-Fang Chiu; Yueh-Hsin Wang; Shwn-Huey Shieh; Wen-Chen Tsai
Journal:  BMC Cancer       Date:  2014-06-17       Impact factor: 4.430

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.